This invention provides methods of treating motor disorder side effects associated with the administration of levodopa to a subject having Parkinsons disease, by administering a dose of eltoprazine or a pharmaceutically acceptable acid addition salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with Parkinsons disease treatments, and effective doses of eltoprazine or a pharmaceutically acceptable acid addition salt thereof.
